Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice

Journal of Nephrology

Volumn 25, Issue 4, 2012, Pages 566-576

  Chen, Yu Q ^a   Wang, Xiao X ^a   Yao, Xing M ^a   Zhang, Dong L ^a   Yang, Xu F ^a   Tian, Shou F ^a   Wang, Nian S ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Diabetic nephropathy; MicroRNA array; Posttranscriptional regulation

Indexed keywords

CASPASE 3; CASPASE 6; CREATININE; GLUCOSE; MICRORNA; MICRORNA 1187; MICRORNA 1196; MICRORNA 192; MICRORNA 1937B; MICRORNA 194; MICRORNA 195; MICRORNA 214; MICRORNA 26B; MICRORNA 320; MICRORNA 34A; MICRORNA 466F; MICRORNA 568; MICRORNA 703; MICRORNA 720; MICRORNA 744; MICRORNA 762; MICRORNA 805; NITROGEN; PROTEIN BCL 2; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; UREA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL EXPANSION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; MALE; MESANGIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ALBUMINURIA; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASPASE 3; CASPASE 8; CELL PROLIFERATION; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; MALE; MESANGIAL CELLS; MICE; MICE, INBRED DBA; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84863977843     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000034     Document Type: Article

References (30)

1. US Renal Data System. USRDS 2003 annual data report. Am J Kidney Dis. 2003;42(6)(Suppl 5):1-230.
2. Chitwood DH, Timmermans MC. Target mimics modulate miRNAs. Nat Genet. 2007;39(8):935-936.
3. Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A. 2007;104(9):3432-3437.
4. Wang Q, Wang Y, Minto AW, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 2008;22(12):4126-4135.
5. Pandey P, Brors B, Srivastava PK, et al. Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics. 2008;9(1):624.
6. Wang G, Kwan BC, Lai FM, et al. Intrarenal expression of microRNAs in patients with IgA nephropathy. Lab Invest. 2010;90(1):98-103.
7. Gurley SB, Clare SE, Snow K P, Hu A, Meyer TW, Coffman TM. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol. 2006;290(1):F214-F222.
8. Liu H, Luo Y, Zhang T, et al. Genetic deficiency of aldose reductase counteracts the development of diabetic nephropa-thy in C57BL/6 mice. Diabetologia. 2011;54(5):1242-1251.
9. Mahimainathan L, Das F, Venkatesan B, Choudhury GG. Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN. Diabetes. 2006;55(7):2115-2125.
10. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20):e179.
11. Saal S, Harvey SJ. MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens. 2009;18(4):317-323.
12. Liang M, Liu Y, Mladinov D, et al. MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol. 2009;297(3):F553-F558.
13. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardio-vasc Res. 2008;79(4):581-588.
14. Kato M, Natarajan R. microRNA cascade in diabetic kidney disease: big impact initiated by a small RNA. Cell Cycle. 2009;8(22):3613-3614.
15. Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol. 2009;4(7): 1255-1266.
16. Zhang Z, Peng H, Chen J, et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett. 2009;583(12):2009-2014.
17. Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol. 2008;19(11):2069-2075.
18. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283(22): 14910-14914.
19. Hennessy E, O'Driscoll L. Molecular medicine of microRNAs: structure, function and implications for diabetes. Expert Rev Mol Med. 2008;10:e24.
20. Khera T, Martin J, Riley S, Steadman R, Phillips AO. Glucose enhances mesangial cell apoptosis. Lab Invest. 2006;86(6): 566-577.
21. Sanchez-Niño MD, Benito-Martin A, Ortiz A. New paradigms in cell death in human diabetic nephropathy. Kidney Int. 2010;78(8):737-744.
22. Durvasula RV, Shankland SJ. Podocyte injury and targeting therapy: an update. Curr Opin Nephrol Hypertens. 2006; 15(1):1-7.
23. Harvey SJ, Jarad G, Cunningham J, et al. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glo-merular disease. J Am Soc Nephrol. 2008;19(11):2150-2158.
24. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol. 2002;13(12):3005-3015.
25. Shi S, Yu L, Chiu C, et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol. 2008;19(11):2159-2169.
26. Stitt-Cavanagh E, MacLeod L, Kennedy C. The podocyte in diabetic kidney disease. ScientificWorldJournal. 2009;9: 1127-1139.
27. Susztak K, Raff AC, Schiffer M, Böttinger E P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic ne-phropathy. Diabetes. 2006;55(1):225-233.
28. Wharram BL, Goyal M, Wiggins JE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol. 2005;16(10): 2941-2952.
29. Baek D, Villén J, Shin C, Camargo FD, Gygi S P, Bartel D P. The impact of microRNAs on protein output. Nature. 2008;455(7209):64-71.
30. Williams AH, Liu N, van Rooij E, Olson EN. MicroRNA control of muscle development and disease. Curr Opin Cell Biol. 2009;21(3):461-469.